与平面成像和单光子发射计算机断层扫描（SPECT）成像相比，正电子发射断层扫描（PET）总是具有优势吗？ - Suppr

Suppr

超能文献

Is PET always an advantage versus planar and SPECT imaging?

作者信息

Mariani Giuliano, Bruselli Laura, Duatti Adriano

机构信息

Regional Center of Nuclear Medicine, University of Pisa Medical School, Via Roma 67, 56126, Pisa, Italy.

出版信息

Eur J Nucl Med Mol Imaging. 2008 Aug;35(8):1560-5. doi: 10.1007/s00259-008-0814-1.

DOI:10.1007/s00259-008-0814-1

PMID:18465125

Abstract

摘要

相似文献

Is PET always an advantage versus planar and SPECT imaging?

Eur J Nucl Med Mol Imaging. 2008 Aug;35(8):1560-5. doi: 10.1007/s00259-008-0814-1.

Planar and SPECT imaging in the era of PET and PET-CT: can it survive the test of time?

Eur J Nucl Med Mol Imaging. 2008 Aug;35(8):1554-9. doi: 10.1007/s00259-008-0813-2.

SPECT radionuclide angiography: it is time for a consensus statement.

Eur J Nucl Med Mol Imaging. 2007 Nov;34(11):1729-34. doi: 10.1007/s00259-007-0496-0.

Future of nuclear medicine: SPECT versus PET.

J Nucl Med. 2009 Jul;50(7):16N-18N.

The future of SPECT in a time of PET.

Nucl Med Biol. 2007 Oct;34(7):733-5. doi: 10.1016/j.nucmedbio.2007.06.013. Epub 2007 Sep 4.

Current practice in pancreatic imaging: the role of nuclear medicine.

Nucl Med Commun. 2006 Jun;27(6):477-80. doi: 10.1097/00006231-200606000-00001.

Will cardiac positron emission tomography ultimately replace SPECT for myocardial perfusion imaging?

J Nucl Cardiol. 2009 Nov-Dec;16(6):841-3. doi: 10.1007/s12350-009-9152-3.

PET-CT--comments on the white paper.

Eur J Nucl Med Mol Imaging. 2008 Aug;35(8):1576. doi: 10.1007/s00259-008-0844-8.

[Molecular imaging with new PET tracers].

Radiologe. 2007 Jan;47(1):8-17. doi: 10.1007/s00117-006-1448-6.

PET versus SPECT: strengths, limitations and challenges.

Nucl Med Commun. 2008 Mar;29(3):193-207. doi: 10.1097/MNM.0b013e3282f3a515.

引用本文的文献

A Review on the Current State and Future Perspectives of [Tc]Tc-Housed PSMA-i in Prostate Cancer.

Molecules. 2022 Apr 19;27(9):2617. doi: 10.3390/molecules27092617.

Rapidly (and Successfully) Translating Novel Brain Radiotracers From Animal Research Into Clinical Use.

Front Neurosci. 2020 Oct 1;14:871. doi: 10.3389/fnins.2020.00871. eCollection 2020.

Image-Guided Drug Delivery with Single-Photon Emission Computed Tomography: A Review of Literature.

Curr Drug Targets. 2015;16(6):592-609. doi: 10.2174/1389450115666140902125657.

Molecular imaging agents for SPECT (and SPECT/CT).

Eur J Nucl Med Mol Imaging. 2014 May;41 Suppl 1:S26-35. doi: 10.1007/s00259-013-2643-0. Epub 2013 Dec 7.

(99m)Tc(N)-DBODC(5), a potential radiolabeled probe for SPECT of multidrug resistance: in vitro study.

J Biol Inorg Chem. 2013 Jun;18(5):523-38. doi: 10.1007/s00775-013-0997-1. Epub 2013 Mar 31.

Is there still a role for SPECT-CT in oncology in the PET-CT era?

Nat Rev Clin Oncol. 2012 Dec;9(12):712-20. doi: 10.1038/nrclinonc.2012.188. Epub 2012 Nov 13.

Synthesis and evaluation of amino acid-based radiotracer 99mTc-N4-AMT for breast cancer imaging.

J Biomed Biotechnol. 2011;2011:276907. doi: 10.1155/2011/276907. Epub 2011 Apr 7.

Matched pairs dosimetry: 124I/131I metaiodobenzylguanidine and 124I/131I and 86Y/90Y antibodies.

Eur J Nucl Med Mol Imaging. 2011 May;38 Suppl 1:S28-40. doi: 10.1007/s00259-011-1772-6. Epub 2011 Apr 12.

Positron emission and single-photon emission imaging: synergy rather than competition.

Eur J Nucl Med Mol Imaging. 2011 Jul;38(7):1189-90. doi: 10.1007/s00259-011-1767-3.

A review on the clinical uses of SPECT/CT.

Eur J Nucl Med Mol Imaging. 2010 Oct;37(10):1959-85. doi: 10.1007/s00259-010-1390-8. Epub 2010 Feb 25.

本文引用的文献

Planar and SPECT imaging in the era of PET and PET-CT: can it survive the test of time?

Eur J Nucl Med Mol Imaging. 2008 Aug;35(8):1554-9. doi: 10.1007/s00259-008-0813-2.

Radionuclide evaluation of the lower gastrointestinal tract.

J Nucl Med. 2008 May;49(5):776-87. doi: 10.2967/jnumed.107.040113. Epub 2008 Apr 15.

PET versus SPECT: strengths, limitations and challenges.

Nucl Med Commun. 2008 Mar;29(3):193-207. doi: 10.1097/MNM.0b013e3282f3a515.

PET imaging problems with the non-standard positron emitters Yttrium-86 and Iodine-124.

Q J Nucl Med Mol Imaging. 2008 Jun;52(2):159-65. Epub 2007 Nov 28.

Impact of target-to-background ratio, target size, emission scan duration, and activity on physical figures of merit for a 3D LSO-based whole body PET/CT scanner.

Med Phys. 2007 Oct;34(10):3854-65. doi: 10.1118/1.2776242.

Hypoxia positron emission tomography imaging with 18f-fluoromisonidazole.

Semin Nucl Med. 2007 Nov;37(6):451-61. doi: 10.1053/j.semnuclmed.2007.07.001.

3,4-dihydroxy-6-[18f]-fluoro-L-phenylalanine positron emission tomography in patients with central motor disorders and in evaluation of brain and other tumors.

Semin Nucl Med. 2007 Nov;37(6):440-50. doi: 10.1053/j.semnuclmed.2007.08.002.

Comparison of image quality of different iodine isotopes (I-123, I-124, and I-131).

Cancer Biother Radiopharm. 2007 Jun;22(3):423-30. doi: 10.1089/cbr.2006.323.

Multi-modality imaging on track.

Eur J Nucl Med Mol Imaging. 2007 Sep;34(9):1410-4. doi: 10.1007/s00259-007-0434-1.

Diagnostic pathways in acute pulmonary embolism: recommendations of the PIOPED II Investigators.

Radiology. 2007 Jan;242(1):15-21. doi: 10.1148/radiol.2421060971.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

Is PET always an advantage versus planar and SPECT imaging?

Eur J Nucl Med Mol Imaging. 2008 Aug;35(8):1560-5. doi: 10.1007/s00259-008-0814-1.

Planar and SPECT imaging in the era of PET and PET-CT: can it survive the test of time?

Eur J Nucl Med Mol Imaging. 2008 Aug;35(8):1554-9. doi: 10.1007/s00259-008-0813-2.

SPECT radionuclide angiography: it is time for a consensus statement.

Eur J Nucl Med Mol Imaging. 2007 Nov;34(11):1729-34. doi: 10.1007/s00259-007-0496-0.

Future of nuclear medicine: SPECT versus PET.

J Nucl Med. 2009 Jul;50(7):16N-18N.

The future of SPECT in a time of PET.

Nucl Med Biol. 2007 Oct;34(7):733-5. doi: 10.1016/j.nucmedbio.2007.06.013. Epub 2007 Sep 4.

Current practice in pancreatic imaging: the role of nuclear medicine.

Nucl Med Commun. 2006 Jun;27(6):477-80. doi: 10.1097/00006231-200606000-00001.

Will cardiac positron emission tomography ultimately replace SPECT for myocardial perfusion imaging?

J Nucl Cardiol. 2009 Nov-Dec;16(6):841-3. doi: 10.1007/s12350-009-9152-3.

PET-CT--comments on the white paper.

Eur J Nucl Med Mol Imaging. 2008 Aug;35(8):1576. doi: 10.1007/s00259-008-0844-8.

[Molecular imaging with new PET tracers].

Radiologe. 2007 Jan;47(1):8-17. doi: 10.1007/s00117-006-1448-6.

PET versus SPECT: strengths, limitations and challenges.

Nucl Med Commun. 2008 Mar;29(3):193-207. doi: 10.1097/MNM.0b013e3282f3a515.

引用本文的文献

A Review on the Current State and Future Perspectives of [Tc]Tc-Housed PSMA-i in Prostate Cancer.

Molecules. 2022 Apr 19;27(9):2617. doi: 10.3390/molecules27092617.

Rapidly (and Successfully) Translating Novel Brain Radiotracers From Animal Research Into Clinical Use.

Front Neurosci. 2020 Oct 1;14:871. doi: 10.3389/fnins.2020.00871. eCollection 2020.

Image-Guided Drug Delivery with Single-Photon Emission Computed Tomography: A Review of Literature.

Curr Drug Targets. 2015;16(6):592-609. doi: 10.2174/1389450115666140902125657.

Molecular imaging agents for SPECT (and SPECT/CT).

Eur J Nucl Med Mol Imaging. 2014 May;41 Suppl 1:S26-35. doi: 10.1007/s00259-013-2643-0. Epub 2013 Dec 7.

(99m)Tc(N)-DBODC(5), a potential radiolabeled probe for SPECT of multidrug resistance: in vitro study.

J Biol Inorg Chem. 2013 Jun;18(5):523-38. doi: 10.1007/s00775-013-0997-1. Epub 2013 Mar 31.

Is there still a role for SPECT-CT in oncology in the PET-CT era?

Nat Rev Clin Oncol. 2012 Dec;9(12):712-20. doi: 10.1038/nrclinonc.2012.188. Epub 2012 Nov 13.

Synthesis and evaluation of amino acid-based radiotracer 99mTc-N4-AMT for breast cancer imaging.

J Biomed Biotechnol. 2011;2011:276907. doi: 10.1155/2011/276907. Epub 2011 Apr 7.

Matched pairs dosimetry: 124I/131I metaiodobenzylguanidine and 124I/131I and 86Y/90Y antibodies.

Eur J Nucl Med Mol Imaging. 2011 May;38 Suppl 1:S28-40. doi: 10.1007/s00259-011-1772-6. Epub 2011 Apr 12.

Positron emission and single-photon emission imaging: synergy rather than competition.

Eur J Nucl Med Mol Imaging. 2011 Jul;38(7):1189-90. doi: 10.1007/s00259-011-1767-3.

A review on the clinical uses of SPECT/CT.

Eur J Nucl Med Mol Imaging. 2010 Oct;37(10):1959-85. doi: 10.1007/s00259-010-1390-8. Epub 2010 Feb 25.

本文引用的文献

Planar and SPECT imaging in the era of PET and PET-CT: can it survive the test of time?

Eur J Nucl Med Mol Imaging. 2008 Aug;35(8):1554-9. doi: 10.1007/s00259-008-0813-2.

Radionuclide evaluation of the lower gastrointestinal tract.

J Nucl Med. 2008 May;49(5):776-87. doi: 10.2967/jnumed.107.040113. Epub 2008 Apr 15.

PET versus SPECT: strengths, limitations and challenges.

Nucl Med Commun. 2008 Mar;29(3):193-207. doi: 10.1097/MNM.0b013e3282f3a515.

PET imaging problems with the non-standard positron emitters Yttrium-86 and Iodine-124.

Q J Nucl Med Mol Imaging. 2008 Jun;52(2):159-65. Epub 2007 Nov 28.

Impact of target-to-background ratio, target size, emission scan duration, and activity on physical figures of merit for a 3D LSO-based whole body PET/CT scanner.

Med Phys. 2007 Oct;34(10):3854-65. doi: 10.1118/1.2776242.

Hypoxia positron emission tomography imaging with 18f-fluoromisonidazole.

Semin Nucl Med. 2007 Nov;37(6):451-61. doi: 10.1053/j.semnuclmed.2007.07.001.

3,4-dihydroxy-6-[18f]-fluoro-L-phenylalanine positron emission tomography in patients with central motor disorders and in evaluation of brain and other tumors.

Semin Nucl Med. 2007 Nov;37(6):440-50. doi: 10.1053/j.semnuclmed.2007.08.002.

Comparison of image quality of different iodine isotopes (I-123, I-124, and I-131).

Cancer Biother Radiopharm. 2007 Jun;22(3):423-30. doi: 10.1089/cbr.2006.323.

Multi-modality imaging on track.

Eur J Nucl Med Mol Imaging. 2007 Sep;34(9):1410-4. doi: 10.1007/s00259-007-0434-1.

Diagnostic pathways in acute pulmonary embolism: recommendations of the PIOPED II Investigators.

Radiology. 2007 Jan;242(1):15-21. doi: 10.1148/radiol.2421060971.